MENU
CAPR
AS OF
Feb 4, 02:45 PM (EDT)
Price
$23.98
Change
-$0.90 (-3.62%)
Capitalization
1.36B
49 days until earnings call
Intraday BUY SELL Signals
+Compare
CAPR
Stock ticker: NASDAQ
AS OF
Feb 4, 02:45 PM (EDT)
Price
$23.98
Change
-$0.90 (-3.62%)
Capitalization
1.36B

CAPR Capricor Therapeutics Forecast, Technical & Fundamental Analysis

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs... Show more

Industry: #Biotechnology
CAPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CAPR with price predictions
Feb 03, 2026

CAPR's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for CAPR moved out of overbought territory on December 30, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 instances where the indicator moved out of the overbought zone. In of the 28 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CAPR entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where CAPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on CAPR as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CAPR moved above its 50-day moving average on February 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CAPR advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

CAPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CAPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.155) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (102.041) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CAPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CAPR is expected to report earnings to fall 5.00% to -51 cents per share on March 25

Capricor Therapeutics CAPR Stock Earnings Reports
Q4'25
Est.
$-0.51
Q3'25
Est.
$-0.54
Q2'25
Missed
by $0.09
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.01
The last earnings report on November 10 showed earnings per share of -54 cents, meeting the estimate of -54 cents. With 67.26K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVEEX16.010.17
+1.07%
Avantis® Emerging Markets Equity Instl
MEQFX19.660.01
+0.05%
AMG River Road Large Cap Value Select I
PYODX46.87-0.23
-0.49%
Victory Pioneer Y
DFUEX33.89-0.22
-0.64%
DFA US Social Core Equity 2 Portfolio
RYNHX159.10-2.10
-1.30%
Rydex Nova H

CAPR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CAPR has been loosely correlated with VRAX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CAPR jumps, then VRAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+7.75%
VRAX - CAPR
48%
Loosely correlated
-1.84%
KRRO - CAPR
33%
Loosely correlated
-2.68%
BEAM - CAPR
33%
Poorly correlated
-0.11%
ACLX - CAPR
32%
Poorly correlated
-0.01%
LXEO - CAPR
32%
Poorly correlated
-1.57%
More